Skip to Main Content
106
Views
4
CrossRef citations to date
Altmetric

Case Reports

Walking ability following hybrid assistive limb treatment for a patient with chronic myelopathy after surgery for cervical ossification of the posterior longitudinal ligament

, , , ORCID Icon, ORCID Icon, , , , , , & show all
Pages 128-136
Published online: 20 Apr 2017
 
Translator disclaimer

Context: The hybrid assistive limb (HAL) (the wearable robot) can assist kinesis during voluntary control of hip and knee joint motion by detecting the wearer's bioelectric signals on the surface of their skin. The purpose of this study was to report on walking ability following the wearable robot treatment in a patient with chronic myelopathy after surgery for cervical ossification of the posterior longitudinal ligament (OPLL).

Findings: The patient was a 66-year-old woman with cervical OPLL who was able to ambulate independently with the aid of bilateral crutches. The wearable robot treatment was received once every 2 weeks for ten sessions beginning approximately 14 years after surgery. Improvements were observed in gait speed (BL 22.5; post 46.7 m/min), step length (BL 0.36; post 0.57 m), and cadence (BL 61.9; post 81.6 m/min) based on a 10-m walk test and a 2-minute walk test (BL 63.4; post 103.7 m) assessing total walking distance. The improvements in walking ability were maintained after the wearable robot treatment for 6 months.

Conclusion: We report the functional recovery in the walking ability of a patient with chronic cervical myelopathy following the wearable robot treatment, suggesting that as a rehabilitation tool, the wearable robot has the potential to effectively improve functional ambulation in chronic cervical myelopathy patients whose walking ability has plateaued, even many years after surgery.

Acknowledgment

We thank Mayuko Sakamaki and Yumiko Ito of the Center for Innovative Medicine and Engineering (CIME) at the University of Tsukuba Hospital for their excellent technical assistance.

Conflicts of Interest

None.

Contributor Statement

A commercial party having a direct financial interest in the results of the research supporting this article has conferred or will confer a financial benefit on 1 or more of the authors. Yoshiyuki Sankai is CEO of Cyberdyne Inc, Ibaraki, Japan. Hiroaki Kawamoto is a stockholder of the Cyberdyne. Cyberdyne is the manufacturer of the robot suit HAL. This study was proposed by the authors. Cyberdyne was not directly involved in the study design, the collection, analysis, or interpretation of data, writing the report, or the decision to submit the paper for publication. No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit on the authors (Shigeki Kubota, Tetsuya Abe, Hideki Kadone, Kengo Fujii, Aiki Marushima, Tomoyuki Ueno, Yukiyo Shimizu, Yasushi Hada, Akira Matsumura, and Masashi Yamazaki) or on any organization with which the authors are associated.

Additional information

Funding

This study was supported by the Industrial Disease Clinical Research Grants of the Ministry of Health Labour and Welfare, Japan (14060101-01).

Log in via your institution

Log in to Taylor & Francis Online

Article Purchase

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 57.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 153.00 Add to cart

* Local tax will be added as applicable
 

Related articles

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.